Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

ClinicalTrials.gov ID: NCT01904409

Public ClinicalTrials.gov record NCT01904409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the efficacy of rifaximin SSD versus placebo in preventing complications of liver cirrhosis, such as all-cause mortality (death due to all causes) or hospitalization, in subjects with early decompensated liver cirrhosis. Rifaximin, a non-systemic antibacterial agent, is currently marketed as a 550 mg tablet for the reduction in risk of recurrent overt hepatic encephalopathy, a complication of liver cirrhosis. The rifaximin SSD tablet was formulated to maximize the efficacy of rifaximin. Subjects will receive 1 of 5 doses of rifaximin SSD tablets or placebo tablets every day for 24 weeks.

Study identification

NCT ID
NCT01904409
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2013 (Type not available)
Primary completion
Jun 2015 (Actual)
Completion
Jul 2015 (Actual)
Last update posted
Oct 23, 2019

2013 – 2015

United States locations

U.S. sites
113
U.S. states
28
U.S. cities
97
Facility City State ZIP Site status
Salix Investigative Site Birmingham Alabama 35294 —
Salix Investigative Site Dothan Alabama 36305 —
Salix Investigative Site Mobile Alabama 36617 —
Salix Investigative Site Tucson Arizona 85712 —
Salix Investigational Site Artesia California 90701 —
Salix Investigational Site Bakersfield California 93301 —
Salix Investigational Site Chula Vista California 91910 —
Salix Investigational Site Coronado California 92118 —
Salix Investigational Site Costa Mesa California 92626 —
Salix Investigative Site Fresno California 93701 —
Salix Investigational Site La Jolla California 92037 —
Salix Investigative Site Los Angeles California 90033 —
Salix Investigational Site Monterey California 93940 —
Salix Investigational Site Riverside California 92377 —
Salix Investigational Site San Diego California 92114 —
Salix Investigational Site Ventura California 93003 —
Salix Investigational Site Englewood Colorado 80113 —
Salix Investigational Site Littleton Colorado 80120 —
Salix Investigational Site Bristol Connecticut 06035 —
Salix Investigational Site New Haven Connecticut 06520 —
Salix Investigational Site Waterbury Connecticut 06708 —
Salix Investigational Site Coral Gables Florida 33134 —
Salix Investigational Site Gainesville Florida 32610 —
Salix Investigative Site Hialeah Florida 33012 —
Salix Investigational Site Hialeah Florida 33016 —
Salix Investigational Site Hollywood Florida 33021 —
Salix Investigative Site Inverness Florida 34452 —
Salix Investigational Site Lake Worth Florida 33449 —
Salix Investigative Site Largo Florida 33777 —
Salix Investigative Site Maitland Florida 32751 —
Salix Investigational Site Miami Florida 33030 —
Salix Investigational Site Miami Florida 33126 —
Salix Investigational Site Miami Florida 33136 —
Salix Investigational Site Miami Springs Florida 33166 —
Salix Investigational Site New Port Richey Florida 34653 —
Salix Investigative Site Orlando Florida 32824 —
Salix Investigational Site Pembroke Pines Florida 33024 —
Salix Investigational Site Port Orange Florida 32127 —
Salix Investigational Site Saint Cloud Florida 34769 —
Salix Investigational Site Tamarac Florida 33319 —
Salix Investigational Site Atlanta Georgia 30309 —
Salix Investigative Site Atlanta Georgia 30342 —
Salix Investigative Site Decatur Georgia 30033 —
Salix Investigational Site Macon Georgia 31201 —
Salix Investigative Site Chicago Illinois 60612 —
Salix Investigative Site Maywood Illinois 75390 —
Salix Investigational Site Evansville Indiana 47714 —
Salix Investigational Site Indianapolis Indiana 46202 —
Salix Investigative Site Iowa City Iowa 52242 —
Salix Investigational Site Bowling Green Kentucky 42101 —
Salix Investigational Site Bastrop Louisiana 71220 —
Salix Investigational Site Monroe Louisiana 71201 —
Salix Investigational Site New Orleans Louisiana 70112 —
Salix Investigational Site Shreveport Louisiana 71103 —
Salix Investigational Site Annapolis Maryland 21401 —
Salix Investigational Site Baltimore Maryland 21202 —
Salix Investigational Site Baltimore Maryland 21228 —
Salix Investigational Site Chevy Chase Maryland 20815 —
Salix Investigational Site Hagerstown Maryland 21743 —
Salix Investigational Site Boston Massachusetts 02114 —
Salix Investigational Site Boston Massachusetts 02115 —
Salix Investigational Site Brockton Massachusetts 02302 —
Salix Investigational Site Springfield Massachusetts 01105 —
Salix Investigative Site Chesterfield Michigan 48047 —
Salix Investigational Site Wyoming Michigan 49519 —
Salix Investigational Site Minneapolis Minnesota 55455 —
Salix Investigative Site Tupelo Mississippi 38801 —
Salix Investigational Site Kansas City Missouri 64131 —
Salix Investigative Site St Louis Missouri 63110 —
Salix Investigational Site Marlton New Jersey 08053 —
Salix Investigational Site New Brunswick New Jersey 07102 —
Salix Investigative Site Brooklyn New York 60153 —
Salix Investigational Site Flushing New York 11040 —
Salix Investigational Site New York New York 10016 —
Salix Investigational Site New York New York 10032 —
Salix Investigational Site Rochester New York 14642 —
Salix Investigative Site The Bronx New York 10467 —
Salix Investigational Site Asheville North Carolina 28801 —
Salix Investigational Site Chapel Hill North Carolina 27599 —
Salix Investigative Site Charlotte North Carolina 28204 —
Salix Investigational Site Charlotte North Carolina 28207 —
Salix Investigational Site Fayetteville North Carolina 28304 —
Salix Investigational Site Wilmington North Carolina 28403 —
Salix Investigational Site Winston-Salem North Carolina 27103 —
Salix Investigative Site Cincinnati Ohio 45224 —
Salix Investigational Site Cincinnati Ohio 45249 —
Salix Investigational Site Cleveland Ohio 44195 —
Salix Investigative Site Dayton Ohio 45415 —
Salix Investigational Site Mentor Ohio 44060 —
Salix Investigational Site Portland Oregon 97210 —
Salix Investigative Site Bristol Tennessee 37620 —
Salix Investigational Site Chattanooga Tennessee 37421 —
Salix Investigational Site Nashville Tennessee 37205 —
Salix Investigational Site Nashville Tennessee 37211 —
Salix Investigative Site Arlington Texas 76012 —
Salix Investigational Site Austin Texas 78705 —
Salix Investigational Site Dallas Texas 75203 —
Salix Investigational Site Dallas Texas 75246 —
Salix Investigative Site Dallas Texas 75390 —
Salix Investigational Site Fort Worth Texas 76104 —
Salix Investigational Site Houston Texas 77005 —
Salix Investigational Site Houston Texas 77030 —
Salix Investigational Site Houston Texas 77090 —
Salix Investigational Site San Antonio Texas 78215 —
Salix Investigational Site San Antonio Texas 78229 —
Salix Investigational Site Bountiful Utah 84010 —
Salix Investigative Site Salt Lake City Utah 84132 —
Salix Investigational Site Charlottesville Virginia 22908 —
Salix Investigative Site Norfolk Virginia 23502 —
Salix Investigative Site Richmond Virginia 23249 —
Salix Investigational Site Richmond Virginia 23298 —
Salix Investigative Site Richland Washington 99352 —
Salix Investigative Site Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01904409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01904409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →